These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29394974)

  • 1. Proteomic Profile of Lymphoid Leukemia.
    Almaiman AA
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):133-145. PubMed ID: 29394974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA as a Biomarker for Diagnosis, Prognosis and Therapeutic Target in Acute and Chronic Lymphoid Leukemia.
    Abohassan M; Khaleel AQ; Pallathadka H; Kumar A; Allela OQB; Hjazi A; Pramanik A; Mustafa YF; Hamzah HF; Mohammed BA
    Cell Biochem Biophys; 2024 Sep; 82(3):1979-1991. PubMed ID: 39136839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
    Singh N; Frey NV; Grupp SA; Maude SL
    Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
    Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
    Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of proteomics between acute myeloid leukemia and acute lymphoid leukemia].
    Xiao P; Zeng YY; Nie YF; Lin W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1353-6. PubMed ID: 22169282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
    Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
    Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of childhood leukemia.
    Hegedus CM; Gunn L; Skibola CF; Zhang L; Shiao R; Fu S; Dalmasso EA; Metayer C; Dahl GV; Buffler PA; Smith MT
    Leukemia; 2005 Oct; 19(10):1713-8. PubMed ID: 16136170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of low abundance mRNA of myeloid specific genes in cells of acute and chronic lymphoid leukemias by cRNA hybridization.
    Ferrari S; Ceccherelli G; Tagliafico E; Zucchini P; Manfredini R; Torelli G; Emilia G; Torelli U
    Leukemia; 1990 Oct; 4(10):688-93. PubMed ID: 2170780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection and significance of minimal residual disease in acute and chronic leukemia.
    Chung NG; Buxhofer-Ausch V; Radich JP
    Tissue Antigens; 2006 Nov; 68(5):371-85. PubMed ID: 17092250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein expression in leukemias.
    Paydas S
    Acta Oncol; 1995; 34(1):23-6. PubMed ID: 7865230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias.
    Veiga Cde S; Carneiro-Lobo TC; Coelho CJ; Carvalho SM; Maia RC; Vasconcelos FC; Abdelhay E; Mencalha AL; Ferreira AF; Castro FA; Monteiro RQ
    Blood Cells Mol Dis; 2011 Mar; 46(3):230-4. PubMed ID: 21216163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute lymphoblastic leukemia and chronic lymphocytic leukemia].
    Machii T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):421-4. PubMed ID: 11212763
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.
    Tooze JA; Hamzic E; Willis F; Pettengell R
    Cancer Genet; 2017 Dec; 218-219():20-38. PubMed ID: 29153094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia.
    Alsagaby SA; Alhumaydhi FA
    Saudi Med J; 2019 Apr; 40(4):317-327. PubMed ID: 30957124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia.
    Thurgood LA; Chataway TK; Lower KM; Kuss BJ
    J Proteomics; 2017 Feb; 155():73-84. PubMed ID: 28069558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cytotoxic effect of quercetin and heat treatment in a lymphoid cell line (OZ) with low HSP70 expression.
    Fujita M; Nagai M; Murata M; Kawakami K; Irino S; Takahara J
    Leuk Res; 1997 Feb; 21(2):139-45. PubMed ID: 9112431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.